Published in Psychosom Med on January 27, 2005
Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative. Am J Epidemiol (2012) 2.20
Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause (2011) 1.61
Sleep duration, insomnia, and coronary heart disease among postmenopausal women in the Women's Health Initiative. J Womens Health (Larchmt) (2013) 1.57
Evaluation and management of sleep disturbance during the menopause transition. Semin Reprod Med (2010) 1.39
The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology (2008) 1.10
Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial. BMC Womens Health (2008) 1.00
A longitudinal investigation of posttraumatic growth in adult patients undergoing treatment for acute leukemia. J Clin Psychol Med Settings (2013) 0.93
25-Hydroxyvitamin D Concentration and Sleep Duration and Continuity: Multi-Ethnic Study of Atherosclerosis. Sleep (2015) 0.89
The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients. J Behav Med (2009) 0.86
Non-pharmacological treatment of insomnia. Neurotherapeutics (2012) 0.85
Association of Sleep Duration and Quality With Alterations in the Hypothalamic-Pituitary Adrenocortical Axis: The Multi-Ethnic Study of Atherosclerosis (MESA). J Clin Endocrinol Metab (2015) 0.83
Insomnia in pregnancy and factors related to insomnia. ScientificWorldJournal (2012) 0.81
NuMoM2b Sleep-Disordered Breathing study: objectives and methods. Am J Obstet Gynecol (2015) 0.80
Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort. Cancer Epidemiol Biomarkers Prev (2014) 0.78
Association of obstructive sleep apnea risk factors with nocturnal enuresis in postmenopausal women. Menopause (2016) 0.77
Healing touch as a supportive intervention for adult acute leukemia patients: a pilot investigation of effects on distress and symptoms. J Soc Integr Oncol (2008) 0.77
Joint associations of insomnia and sleep duration with prevalent diabetes: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Diabetes (2015) 0.76
Sleep quality, duration, and breast cancer aggressiveness. Breast Cancer Res Treat (2017) 0.75
Sleep Duration and Quality in Relation to Autonomic Nervous System Measures: The Multi-Ethnic Study of Atherosclerosis (MESA). Sleep (2016) 0.75
Sleep Trajectories Before and After the Final Menstrual Period in The Study of Women's Health Across the Nation (SWAN). Curr Sleep Med Rep (2017) 0.75
Effects of estrogen with and without progestin on urinary incontinence. JAMA (2005) 5.41
Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol (2006) 3.53
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med (2013) 2.38
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2007) 2.25
Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess (2003) 2.10
Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab (2006) 2.03
Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol (2004) 1.82
Sleep duration and risk of ischemic stroke in postmenopausal women. Stroke (2008) 1.80
Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol (2006) 1.66
Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene. J Clin Oncol (2009) 1.54
Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess (2003) 1.52
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2007) 1.52
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials (2004) 1.52
Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial. J Bone Miner Res (2006) 1.45
The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y). Brain Res (2013) 1.44
Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer (2010) 1.39
Harvard report on cancer prevention, volume 5: fulfilling the potential for cancer prevention: policy approaches. Cancer Causes Control (2002) 1.29
Breast cancer survivors' health-related quality of life : racial differences and comparisons with noncancer controls. Cancer (2008) 1.28
Perception of child vulnerability among mothers of former premature infants. Pediatrics (2004) 1.26
Validation of a cognitive assessment battery administered over the telephone. J Am Geriatr Soc (2012) 1.26
Type 2 diabetes mellitus and cognition: an understudied issue in women's health. J Psychosom Res (2003) 1.21
Medical students' attitudes toward underserved patients: a longitudinal comparison of problem-based and traditional medical curricula. Adv Health Sci Educ Theory Pract (2006) 1.17
Analysis of outcomes of anterior cruciate ligament repair with 5-year follow-up: allograft versus autograft. Arthroscopy (2005) 1.13
Stress and adaptation in mothers of children with cerebral palsy. J Pediatr Psychol (2003) 1.13
Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol (2009) 1.07
Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment. Breast Cancer Res Treat (2013) 1.06
Quantification of upper extremity function and range of motion in children with cerebral palsy. Dev Med Child Neurol (2008) 1.04
Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause (2003) 1.03
Explaining age-related differences in depression following breast cancer diagnosis and treatment. Breast Cancer Res Treat (2012) 0.99
The case for domains of function in quality of life assessment. Qual Life Res (2003) 0.97
High dimensional classification of structural MRI Alzheimer's disease data based on large scale regularization. Front Neuroinform (2011) 0.96
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial. Clin J Am Soc Nephrol (2010) 0.95
Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies. Neurology (2014) 0.94
Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients. Am J Kidney Dis (2011) 0.93
Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia. Diabetes Care (2010) 0.92
Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition. J Womens Health (Larchmt) (2010) 0.88
Demographic and health factors associated with enrollment in posttrial studies: the Women's Health Initiative Hormone Therapy Trials. Clin Trials (2013) 0.86
A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. J Support Oncol (2013) 0.85
Women's health initiative view of estrogen avoidance and all-cause mortality. Am J Public Health (2013) 0.84
Health-related quality-of-life findings for the prostate cancer prevention trial. J Natl Cancer Inst (2012) 0.81
Long-term exercise therapy resolves ethnic differences in baseline health status in older adults with knee osteoarthritis. J Am Geriatr Soc (2005) 0.80
Proteomic patterns in serum and identification of ovarian cancer. Lancet (2002) 0.80
Baseline health-related quality of life in postmenopausal women with coronary heart disease: the Estrogen Replacement and Atherosclerosis (ERA) trial. J Womens Health (Larchmt) (2003) 0.79
Race, poverty, affluence, and breast cancer. Am J Public Health (2002) 0.78
Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes. J Clin Lipidol (2011) 0.78
Behavior-based interventions to enhance cognitive functioning and independence in older adults. JAMA (2006) 0.77
Female sex work within the rural immigrant Latino community in the southeast United States: an exploratory qualitative community-based participatory research study. Prog Community Health Partnersh (2012) 0.77
Discriminatory accuracy of a risk prediction model. Biostatistics (2005) 0.75
Association of sleep disturbance and sexual function in postmenopausal women. Menopause (2017) 0.75
Importance of disclosure of patent applications. Lancet (2004) 0.75
Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106. J Community Support Oncol (2015) 0.75
Traditional risk factors for coronary heart disease. JAMA (2004) 0.75
Creation of a grant support service within a Women's Health Center of Excellence: experiences and lessons learned. J Womens Health (Larchmt) (2006) 0.75
Sex differences in career progress and satisfaction in an academic medical center. J Am Med Womens Assoc (2002) 0.75
When practices, promises, profits, and policies outpace hard evidence: the post-menopausal hormone debate. J Soc Issues (2005) 0.75